Title : Comorbidity and low use of new antiplatelets in acute coronary syndrome.

Pub. Date : 2020 Aug

PMID : 31542850






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 INTRODUCTION: Despite the use of the new generation P2Y12 inhibitors (Ticagrelor and Prasugrel) with aspirin is the recommended therapy in acute NSTE-ACS patients, their current use in clinical practice remains quite low and might be related, among several variables, with increased comorbidity burden. Prasugrel Hydrochloride purinergic receptor P2Y12 Homo sapiens